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Abstract 
 
     Over 30,000 people receive a solid organ transplant each year, with 5-30% developing post-
transplant diabetes mellitus (PTDM) (United Networking for Organ Sharing, 2015).  At a 
Midwestern transplantation center, over 22% of patients with a history of diabetes were not 
consulted to endocrinology after kidney and liver transplantation.  With poor glycemic control, 
there is an increased risk of developing PTDM leading to poor outcomes.  Utilizing the 
Donabedian model and the Six Sigma’s Define, Measure, Analyze, Improve, and Control 
(DMAIC) as guides for implementation, the purpose of this project was to address the process 
measures of increasing appropriate consultations for evaluation and treatment of PTDM patients 
that would lead to an important quality measure of improved glycemic control for this 
population.  The project involved the implementation of a clinical pathway to address this quality 
measure.  Even though there was not a statistically significant change in number of consultations, 
there was a clinical meaningful difference because the patients who were consulted after 
pathway implementation received the benefit of management by endocrinology specialists to 
improve glycemic control post transplantation.  Limitations of the project leading to the reported 
results include that the sample size was less than 30 and the period of evaluation was only one 
month.  The recommendation is for transplant and endocrinology teams to continue to work 
together to develop clinical pathways to appropriately consult endocrinology teams that is 
consistent with the standardized care of other organ transplants.  Though this is a small piece to a 
larger problem, the use of standardized pathways will potentially improve care leading to 
improved glycemic control in the kidney and liver transplant population.  Early consultation 
immediately after surgery will potentially improve the transitions of care from inpatient to 
outpatient setting for this patient population. 
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Executive Summary 
     Close to 30,000 people receive a solid organ transplant each year in the United States, 5% -
30% develop post-transplant diabetes mellitus (PTDM) (United Networking for Organ Sharing, 
2015).  This wide range of incidence is likely due to the inconsistent definition of PTDM.  
PTDM, formerly called new onset diabetes after transplantation (NODAT), has been recognized 
as a complication after transplantation since the early 1960’s (Stevens, Patel, & Jardine, 2012).  
In 2014, the International Consensus Guidelines changed the terminology from NODAT to 
PTDM to address the condition occurring in the post transplantation setting regardless if it was 
present but undetected prior to transplantation (Sharif et al., 2014).  The condition can be 
diagnosed only 30-45 days after transplantation.  These guidelines also recommended the term 
“pre-diabetes mellitus” to be used for patients with post-transplant hyperglycemia who have not 
surpassed the threshold values for the diagnosis of PTDM (Sharif et al., 2014).   
     There are several risk factors for PTDM that include age, obesity, African-American race and 
Hispanic ethnicity, family history, impaired glucose tolerance, Hepatitis C virus, 
immunosuppression therapy, underlying kidney disease, HLA mismatches, and induction therapy 
(Wilkinson et al., 2005).  Patients who are diagnosed with PTDM have close to an 80% increase 
in mortality from any cause and over a 45% increase in mortality from cardiovascular disease 
(Cosio, Hickson, Griffin, Stegall, & Kudva, 2008).  This condition is also linked to a 24% 
increase risk of graft failure along with acute rejection (Cole, Johnston, Rose, & Gill, 2008).   
     A midwestern transplantation center, a division of a large academic medical center, has 
ranked in the top 20% nationally in patient outcomes as well as the number of transplants 
performed.  This center serves as the largest and most successful transplantation program in the 
midwest (Hospital in Midwest, 2015).  Despite the high quality that this center provides for their 
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patients, PTDM is still a concern, as with almost all transplant centers.  Between November 1, 
2014 and February 28, 2015, this center performed over 100 transplants.  Over 20% of kidney 
and liver transplant patients with a history of diabetes were not consulted by endocrinology for 
proper glycemic control.  With poor glycemic control (BG<70 mg/dL, BG>140 mg/dL), there is 
an increased risk of these patients developing PTDM. 
     Currently there is no integration of diabetes management into the primary transplant team 
decisions causing lack of glycemic control, lack of or delayed endocrinology consultation, and 
lack of formal diabetes education after transplantation occurs.  Heart and lung transplant patients 
receive endocrinology consultation, whereas the kidney and liver transplant patients do not.  The 
lack of standardized care among these transplant patients has been confusing for nursing staff but 
has also been part of the health care culture for over a decade.   
     Effective interventions for this population include identifying patients at risk, performing 
early and repetitive screening, and aggressively treating patients with PTDM (Rakel & Karelis, 
2011).  Boerner, Shivaswamy, Goldner, and Larsen (2015) discuss how the collaboration with 
multidisciplinary teams will result in improved glycemic control and decrease the risk of PTDM 
in the post-transplant population.  Early consultation with the endocrinology team is one example 
of this phenomenon, which not only improves patient outcomes but eases the burden of the 
primary transplant team (Boerner et al., 2015).  Evidence suggests that with pathways in place to 
guide appropriate consultation with endocrinology, treatment to control blood sugar is initiated 
earlier.   
     The purpose of this project was to address the process measures of increasing appropriate 
consultations for evaluation and treatment of PTDM patients that would lead to an important 
quality measure of improved glycemic control for this population.  This was addressed by 
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answering the clinical question: Will appropriate consultations to the endocrinology service 
occur in patients with abnormal glucose in the post-transplant period after initiation of a nurse 
driven clinical pathway? 
     The conceptual frameworks of the Donabedian model and the DMAIC quality improvement 
processes to guide this quality improvement project involved the implementation of a clinical 
pathway to address this quality measure.  Even though there was not a statistically significant 
change in the number of consultations, there was a clinical meaningful difference because the 
patients who were consulted after pathway implementation received the benefit of management 
by endocrinology specialists to improve glycemic control post transplantation.  Limitations of 
the project leading to the reported results included that the sample size was less than 30 and the 
period of evaluation was only one month.  For project sustainability, it was recommended that a 
longer evaluation period occur to assess for statistically significant improvement regarding the 
number of consultations initiated with this pathway.  With transplantation highly regulated, these 
interventions will not only affect patient outcomes and improve patient safety; but could improve 
the center’s approval status with Centers for Medicare and Medicaid Services (CMS) by 
improving transplantation outcomes (Centers for Medicare & Medicaid Services, 2015). 
     Cost considerations for this project required human resources and time of the endocrinology 
team working together to approve a clinical pathway for endocrinology consultation.  Additional 
resources involved the time necessary to train nursing staff on the pathway implementation as 
well as the financial cost of sustainability, cost of in-services, and the use of conference rooms 
for the in-services.  Furthermore, the cost of time from stakeholders, managers, educators, 
endocrine service, transplant team, and the Doctor of Nursing Practice (DNP) student to review, 
approve, and implement the quality improvement project was taken into consideration.  Even 
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with these cost considerations, there is an estimated potential yearly cost savings as high as 
$292,864.24 for kidney transplant patients and as high as $220,704.24 for liver transplant 
patients if glycemic control could be improved.  The recommendation is for transplant and 
endocrinology teams to continue to work together to develop clinical pathways to appropriately 
consult endocrinology teams that is consistent with the standardized care of other organ 
transplants.  Though this is a small piece to a larger problem, the use of standardized pathways 
will potentially improve care leading to improved glycemic control in the kidney and liver 
transplant population.  Early consultation immediately after surgery will potentially improve the 
transitions of care from inpatient to outpatient setting for this patient population. 
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Quality Improvement Initiative in Transplant Diabetes Care: Needs Assessment and Protocol 
Development 
     Of the 30,000 people receiving a solid organ transplant each year in the United States, 5% -
30% develop post-transplant diabetes mellitus (PTDM) (United Networking for Organ Sharing, 
2015).  The wide range of incidence is likely due to the inconsistent definitions of PTDM.  
PTDM, formerly called new onset diabetes after transplantation (NODAT), has been recognized 
as a complication after transplantation since the early 1960’s (Stevens, Patel, & Jardine, 2012).  
In 2014, the International Consensus Guidelines changed the terminology from NODAT to 
PTDM to address the condition occurring in the post transplantation setting regardless if it was 
present, but undetected prior to transplantation (Sharif et al., 2014).   
     PTDM is associated with increase cardiovascular morbidity, reduced graft function, and lower 
survival rates among patients (Midtvedt et al., 2011).  From an organizational standpoint, organ 
transplantation is highly regulated.  The Centers for Medicare and Medicaid Services (CMS) and 
Organ Procurement and Transplant Network (OPTN), serve as regulating bodies for transplant 
centers (Scientific Registry of Transplant Recipients, 2015).  Patient outcomes do not affect 
reimbursement to an organization, however poor patient outcomes do affect regulatory review, 
particularly CMS certification (Centers for Medicare & Medicaid Services, 2015).  
Problem Statement 
     Patients who are diagnosed with PTDM have close to an 80% increase in mortality from any 
cause and over a 45% increase in mortality from cardiovascular disease (Cosio, Hickson, Griffin, 
Stegall, & Kudva, 2008).  This condition is also linked to a 24% increase risk of graft failure 
along with acute rejection (Cole, Johnston, Rose, & Gill, 2008).  At one transplant center, over 
20% of kidney and liver transplant patients with a history of diabetes were not consulted by the 
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endocrinology team for evaluation and treatment of abnormal glucose levels.  Of these patients 
not consulted, 51% of kidney transplant patients recorded having two or more readings of blood 
glucose (BG) levels less than 60 mg/dL during their hospital stay.  Whereas, 67% of liver 
transplant patients not consulted recorded having two or more readings of blood glucose (BG) 
levels greater than 200 mg/dL.  With poor glycemic control (BG<70 mg/dL, BG>140 mg/dL), 
there is an increased risk of these patients developing PTDM.  Currently, PTDM accounts for 
roughly over $21,000 per patient over two years when compared with those patients who did not 
develop PTDM (Woodward et al., 2003).  If this trend continues, health care costs will rise, 
patient outcomes will decline, and transplant centers will struggle to maintain CMS certification.  
Appropriate consultation to the endocrinology service for at risk patients is one treatment to 
improve glycemic control.  Looking at this small piece of the puzzle, the clinical question is: 
Will appropriate consultations to the endocrinology service be initiated in patients with abnormal 
glucose in the post-transplant period after initiation of a nurse driven clinical pathway?  
Exploring the current literature of risk factors for PTDM as well as interventions to improve 
glycemic control will assist in addressing this clinical question.  
Evidence-Based Initiative 
     The 2014 International Consensus Guidelines by Sharif et al. (2014) classify PTDM as:  
 Symptoms of hyperglycemia (i.e., polyuria, polydipsia, polyphagia), plus random plasma 
glucose ≥200 mg/dL (11.1 mmol/L) and/or 
 Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) on at least two occasions and/or 
 Two hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during an oral glucose tolerance 
test (OGTT) and/or 
 Hemoglobin A1C (A1C) level ≥6.5%. 
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The timeframe for diagnosis of PTDM is only 30-45 days after transplantation.  These guidelines 
also recommended the term “pre-diabetes mellitus” to be used for patients with post-transplant 
hyperglycemia who have not surpassed the threshold values for the diagnosis of PTDM (Sharif et 
al., 2014).   
     Several risk factors associated with PTDM have been identified in the literature.  Common 
risk factors among all solid organ transplantations are heredity, obesity, hepatitis C (HCV), 
cytomegalovirus (CMV) virus, and tacrolimus use (Marchetti, 2005; Mirabella et al., 2005).  
Specific risk factors for kidney transplantation include age, race/ethnicity, family history of 
diabetes, immunosuppression therapy, induction therapy, and hyperglycemia before and/or after 
transplantation.  Of these risk factors, Cosio, Pesavento, Osei, Henry, & Ferguson (2001) 
determined age over 45 in transplant recipients was the strongest and most consistent risk factor 
for PTDM in kidney transplantation.  Obesity, African American and Hispanic descent, and the 
other common risk factors also contributed to PTDM in this population (Kasiske et al., 2003; 
Friedman, Miskulin, Rosenberg, & Levey, 2003; Santos et al., 2012; Shah et al., 2006).     
     Basiliximab (Simulect) induction therapy has proven to be effective in reducing the rate of 
acute rejections as well as limit the dosages of calcineurin inhibitors and steroids necessary in the 
early post transplantation period (Vincenti et al., 2006).  However, previous studies suggest an 
increased incidence of PTDM in patients who received basiliximab (Aasebo et al., 2010; Bayes 
et al., 2007).   
     Effective interventions for this population include identifying patients at risk, performing 
early and repetitive screening, and aggressively treating patients with PTDM (Rakel & Karelis, 
2011).  Boerner, Shivaswamy, Goldner, and Larsen (2015) discuss how the collaboration with 
multidisciplinary teams will result in improved glycemic control and decrease the risk of PTDM 
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in the post-transplant population.  Early consultation with the endocrinology team is one example 
of this phenomenon, which not only improves patient outcomes but eases the burden of the 
primary transplant team (Boerner et al., 2015).   
     At the Medical University of South Carolina (MUSC), the endocrinology department 
developed a Diabetes Management Service (DMS) that provides 24/7 concurrent care for the 
management of hyperglycemia and diabetes-related consults to all adult inpatient units.  This 
organization found that DMS involvement tended to reduce graft failure rates from 20% to 6% in 
renal transplant patients (Medical University of South Carolina, 2015).  From these results, DMS 
coordinated post-discharge follow up visits to reduce the readmission rates related to poor 
glycemic control.  Currently, at this study organization, all diabetic renal transplant patients are 
seen by the endocrinology team weekly for the first four weeks post transplantation.  This 
appointment is on the same day as their transplant clinic follow up.  MUSC also determined that 
early consultation of DMS in patients with glycemic control issues resulted in significantly 
shorter length of stay compared to other patients (Medical University of South Carolina, 2015). 
     Another organization studied the post-operative glycemic control in heart transplant patients.  
In this retrospective study, the Glucose Management Service (GMS) implemented inpatient 
insulin protocols to obtain glycemic control in patients with and without diabetes.  The time 
period from the time the insulin drip was initiated until it was discontinued was defined as the IV 
insulin protocol time period.  The transition protocol consisted of insulin glargine given daily.  
As part of the protocol, patients were seen daily by a member of the GMS team to determine the 
insulin response of each patient.  Insulin was reduced daily as the reduction in postoperative 
stress and steroid dosing decreased.  Nurse practitioners could deviate from this protocol and 
individualize care.  The results indicated that with the use of these protocols, heart transplant 
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patients reported postsurgical outcomes at 30 days with adequate control of blood glucose with 
minimal hypoglycemia events.  With the implementation of glycemic control protocols, 
postsurgical outcomes improved (Wallia et al., 2014). 
     The same organization that initiated insulin protocols in heart transplant patients analyzed 
glycemic control by the Glucose Management Service (GMS) and infection rates in liver 
transplantation.  The retrospective study evaluated 73 liver transplant recipients who were treated 
with insulin infusions, before and after introduction of GMS.  The purpose of the study was to 
analyze patients who were followed by GMS compared to non-GMS management.  The results 
indicated that the number of days in the intensive care unit as well as the length of stay (LOS) in 
the hospital was greater in the non-GMS group than the GMS group.  Also infection rates in the 
GMS group were lower than for the non-GMS group (Wallia et al., 2011).  Based on these 
outcome measures, within one year post liver transplantation, outcomes of patients followed by 
the GMS was associated with improved glycemic control and decreased postoperative infections 
(Wallia et al., 2011). 
     Since there is an inconsistent definition of PTDM, proper identification of patients at risk of 
PTDM, and with utilization of the evidence from the current literature, interventions can be 
implemented to improve glycemic control in a transplant center.  Evidence suggests that with 
pathways in place to guide appropriate consultation with endocrinology, treatment to control 
blood sugar is initiated.  With appropriate glycemic treatment, patient outcomes can be 
improved.  
 
 
 
QUALITY IMPROVEMENT INITIATIVE IN TRANSPLANT 15 
Conceptual Models 
The Donabedian Model 
     Conceptual models serve as frameworks needed to explain the phenomenon and guide 
interventions.  The Donabedian model is a conceptual model that provides a framework for 
examining health services and evaluating quality of health care (Donabedian, 1988).  Avedis 
Donabedian, a physician and health services researcher at the University of Michigan, first 
developed the model in 1966.  According to the model, there are three categories: structure, 
process, and outcomes (See Appendix A).  Structure describes the context of the setting in which 
care is delivered.  This can include material resources from the hospital building, staff, methods 
of reimbursement, and equipment.  The process denotes the transactions between patients and 
providers including pathways and measures to deliver care.  Finally, outcomes refer to the effects 
on the health status of patients and populations in response to structure and process (Donabedian, 
1988).  This model was developed to be flexible enough for application in diverse healthcare 
systems and among various levels within a delivery system.  The model can be used to modify 
structures and processes within a healthcare delivery system such as improving glycemic control 
by developing protocols to guide early consultation with endocrinology.  With improved 
processes and structure established, this model draws connections to improve patient outcomes, 
which are vital to this phenomenon.  The Donabedian model will serve as a framework to guide 
interventions in this proposal along with another methodology to implement process 
improvements.  
Six Sigma 
     Six sigma is a method that provides organizations tools to improve processes and increase 
performance.  The decrease in process variation and increase in performance improves outcomes, 
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employee morale, and quality of services provided (Pande, Neuman, & Cavanagh, 2002).  This 
perspective is data and fact driven, utilizing qualitative and quantitative techniques to drive 
process improvement (Pande, Neuman, & Cavanagh, 2002).  Tools that illustrate this process can 
be in the form of diagrams, control charts, processing mapping, and failure mode and effects 
analysis (Pande, Neuman, & Cavanagh, 2002).   
     Process improvement strategies eliminate the root causes of performance problems in an 
organization, which is an integral part of six sigma.  DMAIC (define, measure, analyze, improve, 
and control) is an acronym for the five phases used in six sigma methodology (Pande, Neuman, 
& Cavanagh, 2002) (See Appendix B).   
     Each step in the DMAIC process is required to ensure the best possible result: 
 Define the problem, project boundaries, and process to be improved by performing an 
organizational assessment (Pande, Neuman, & Cavanagh, 2002). 
 Measure the process performance through data collection from multiple sources (Pande, 
Neuman, & Cavanagh, 2002). 
 Analyze the data collected and process map to determine root causes of poor performance 
and identify gaps between current performance and goal performance (Pande, Neuman, 
& Cavanagh, 2002). 
 Improve process performance by developing solutions addressed in the root causes 
(Pande, Neuman, & Cavanagh, 2002). 
 Control the improved process and future process performance by implementing 
continuous monitoring and incentives for quality improvement (Pande, Neuman, & 
Cavanagh, 2002). 
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     The DMAIC approach is a conceptual framework that guides an organization through process 
and quality improvements.  An organization can employ this methodology to illustrate root 
causes for poor glycemic control as well as improve the process measures to recognize and 
intervene on the risk factors associated with PTDM.  The organization has successfully used this 
framework for quality improvement project work in the past and staff are familiar with this 
process.  This was the reason this framework was chosen to guide the project intervention.  
Need and Feasibility Assessment of the Organization/Population 
     A midwestern transplantation center, a division of a large academic medical center, has been 
providing solid organ transplantations since 1964 (Hospital in Midwest, 2015).  Ranking in the 
top nationally in patient outcomes as well as the number of transplants performed, this center 
serves as the largest and most successful transplantation program in the midwest (Hospital in 
Midwest, 2015).  With over 200 kidney and 100 liver transplants performed yearly, this center 
offers five satellite clinics to provide convenient and exceptional patient care while sustaining 
the mission, values, and vision of the academic medical center.   
     There is a strong external environment within this organ transplantation center.  Centers for 
Medicare and Medicaid Services (CMS) and Organ Procurement and Transplant Network 
(OPTN), the regulating bodies for transplant centers, receive data on all solid organ transplants 
and donations from The Scientific Registry of Transplant Recipients (SRTR) (Scientific Registry 
of Transplant Recipients, 2015).  Transplant centers receive generated reports from SRTR every 
six months.  
     In the summer of 2014, three reports were released at once regarding quality measures.  The 
center did not meet quality standards on two of the three reports in patient survival and graft 
survival resulting in lack of compliance for CMS (G. McNatt, personal communication, October 
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15, 2015).  This resulted in a mitigating factors report to CMS as well as an overhaul within the 
organization.  An organizational assessment plan was developed to ensure that these citations 
would be resolved. 
     A nephrologist at the center developed Real-time Analysis and Performance Improvement 
Dashboard (RAPID) to monitor the performance of patient and graft survival (Hospital in 
Midwest, 2015).  With the one year lag time with SRTR, this dashboard allowed centers to 
identify performances that may trigger regulatory review by United Network for Organ Sharing 
(UNOS) or CMS.  
     The center also analyzed patient outcomes along with patient satisfaction rates.  This analysis 
resulted in each patient being assigned a nephrologist and nurse coordinator before their 
discharge from the hospital.  The nurse coordinator made weekly phone calls to the patients as 
well as the patient was seen in the clinic more frequently.  This intent was not only to improve 
continuity of care but improve patient satisfaction.  
    To improve patient outcomes, the center evaluated the types of patients transplanted at the 
center and decreased the age of recipients they would transplant.  They also developed new 
protocols to assess patients before they were listed for transplantation.  This involved utilizing 
the Montreal Cognitive Assessment (MoCA) and the Timed Up and Go test (TUG) to assess 
patient’s cognitive status and frailty.  Depending on these results, patients were either sent to a 
gerontologist or physical therapy for further evaluation on cognition and frailty.  
     Within a year, the center noticed remarkable improvement with patient satisfaction as well as 
patient outcomes.  However, patients were still seen in the clinic with abnormal glucose levels 
and the staff believed this was out of their scope of practice.  There was concern about glycemic 
control within the first 30 days post-transplantation.  In August 2015, members of the transplant 
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quality team reached out to the endocrinology team at the academic center requesting their 
assistance on this problem.  
     At the Glycemic Control Committee (GCC) meeting held in August 2015, assessment data 
and key stakeholders were identified.  With the current health care culture at CTC, the 
endocrinology team explored how many endocrinology consultations were initiated by the 
transplant team with kidney and liver transplant patients.  The GCC recognized that this has been 
a constant issue over the years because several members of the endocrinology team as well as 
transplant team have opposing views of glycemic control in post-transplant patients.  Attendees 
at the meeting agreed to follow up in October 2015 after gathering data to determine if there was 
a need for endocrinology consultation with transplant patients.   
     An organizational assessment was performed as well as a SWOT analysis, illustrating 
potential barriers, challenges, and threats that could cause problems for implementation of a 
proposed project of improving glycemic control (See Appendix C).  This organizational 
assessment also assessed the current practices for glycemic control among all transplant patients.  
The heart and lung transplant patients receive endocrinology consultation, whereas the kidney 
and liver transplant patients on the same unit do not.  The lack of standardized care among these 
transplant patients has been confusing for nursing staff but has also been part of the health care 
culture for over a decade.  From the organizational assessment, a fishbone diagram was 
developed that determined reasons for poor glycemic control (See Appendix D).  As part of the 
organizational assessment, information was gathered that determined that over 20% of patients 
with a history of diabetes were not consulted by endocrinology (See Appendix E).  Of these 
patients not consulted, 51% of kidney transplant patients recorded having two or more readings 
of blood glucose (BG) levels less than 60 mg/dL during their hospital stay.  Whereas, 67% of 
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liver transplant patients not consulted recorded having two or more readings of blood glucose 
(BG) levels greater than 200 mg/dL (See Appendix F).  The organizational assessment also noted 
that several of the patients transplanted had many risk factors associated with PTDM (See 
Appendix G).  Since glycemic control affects patient outcomes and from the information 
collected during the organizational assessment, the director of CTC and the transplant surgeons 
agreed that this was a concern that needed to be addressed. 
Project Plan 
 Purpose of the Project  
     The purpose of this project was to address the process measures of increasing appropriate 
consultations for evaluation and treatment of PTDM patients that would lead to an important 
quality measure of improved glycemic control for this population.  This was addressed by 
answering the clinical question: Will appropriate consultations to the endocrinology team occur 
in patients with abnormal glucose in the post-transplant period after initiation of a nurse driven 
clinical pathway? 
Objectives 
     Efforts to improve glycemic control in post-transplant patients was evaluated by developing a 
quality improvement process that: 
 Created and implemented a nurse driven clinical pathway that established criteria for 
endocrinology consultation in kidney and liver transplantation on May 2, 2016. 
 Evaluated knowledge of nursing staff after in-service and implementation of nurse driven 
clinical pathway on May 2, 2016. 
 Analyzed data on the number of consultations that were obtained after pathway 
implementation on June 7, 2016. 
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 Evaluated if appropriate consultations to endocrinology were initiated on June 7, 2016. 
Type of Project 
     The project was a quality improvement (QI) initiative.  QI “consists of systemic and 
continuous actions that lead to measureable improvement in health care services and the health 
status of targeted patient groups” (HRSA, 2011, p. 2).  QI is directly linked to the delivery 
approach and systems of care within an organization.  To improve quality, the current system of 
care requires change within an organization.  This is obtained following four key principles: QI 
in systems and processes, focus on patients, focus on team approach, and focus on use of data 
(HRSA, 2011).   
     Within in this project, the systems and processes as well as the focus of a team approach was 
evaluated during an organizational assessment (see Appendix C).  Utilizing data that determined 
poor glycemic control in this population and how patient outcomes were affected, members of 
the transplant and endocrinology teams initiated actions to develop ways to improve glycemic 
control.  
Setting and Needed Resources 
     The setting for implementation of this project occurred on the cardiac transplant intensive 
care unit (CTICU) and the step down floor for transplant patients at the academic medical center.  
The resources needed to complete this project included physicians from transplant surgery, 
endocrinology team, pharmacy, quality leaders from transplant, project coordinator from the  
endocrinology service, nurse practitioners from endocrinology and transplant services, and 
nurses from CTICU and the step down unit.  Other resources included agreement from members 
of the endocrinology service to agree upon a pathway, set time aside to educate all staff on the 
implementation of this pathway, and finally after implementation was completed, utilized the 
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quality teams to gather data to determine if consultations to the endocrinology service increased 
and were appropriate.  Other resources considered were the support from the unit managers as 
well as the additional time within the current work day for staff to attend the in-service to learn 
about the clinical pathway implementation. 
Design for the Evidence-based Initiative 
     DMAIC was the conceptual model used to guide the interventions for this project (See 
Appendix B) (Pande et al., 2002).        
 Define the problem: Patients who are diagnosed with PTDM have close to an 80% 
increase in mortality from any cause and over a 45% increase in mortality from 
cardiovascular disease (Cosio, Hickson, Griffin, Stegall, & Kudva, 2008).  This condition 
is also linked to a 24% increase risk of graft failure along with acute rejection (Cole, 
Johnston, Rose, & Gill, 2008).  Currently the organization does not have protocols in 
place to screen patients for diabetes or process measures to improve appropriate 
consultations to the endocrinology service.  Increasing appropriate consultations for 
evaluation and treatment of PTDM patients would lead to an important quality measure 
of improved glycemic control for this population.  From the organizational assessment, 
there was evidence that poor glycemic control exists in this patient population.  
 Measure: Over 20% of patients with history of diabetes were not consulted to the 
endocrinology service.  Of these patients not consulted, 51% of kidney transplant patients 
recorded having two or more readings of blood glucose (BG) levels less than 60 mg/dL 
during their hospital stay.  Whereas, 67% of liver transplant patients not consulted 
recorded having two or more readings of blood glucose (BG) levels greater than 200 
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mg/dL.  Several of the patients transplanted had many risk factors associated with 
PTDM.  These risk factors are associated with poor outcomes in this patient population.  
 Analyze: Analyze the data from the organizational assessment.  A fishbone diagram was 
developed concluding that poor glycemic control in this organization was multifactorial.  
 Improve process performance: Utilizing evidence from the literature as well as the 
information gathered from the organizational assessment, members of the endocrinology 
team met to discuss quality improvements.  This team worked together to develop criteria 
for consulting the endocrinology service within this patient population as well as 
discussed ways to implement a pathway for sustainability. 
 Control: Once pathway was implemented, data was measured and analyzed to determine 
if the pathway improved consultations as well as determined if the consultations were 
appropriate.  Once information was gathered, data was disseminated to endocrinology 
and transplant teams.  This information can then be used to develop pathways for the 
outpatient setting.  Based on the current literature, over time appropriate consultations to 
endocrinology will support the transition plan to primary care for improve glycemic 
control in the outpatient setting.  
Participants 
     The participants included any patient who received a kidney or liver transplant, nursing staff 
caring for this population, the GMS service, and transplant quality leaders.  The nursing staff was 
responsible to recognize which transplant patients met criteria for consultation while the quality 
leader was responsible for providing data to determine if consultation occurred.   
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Measurement: Sources of Data and Tools 
     Data was collected by the DNP student and quality leaders one month after the pathway was 
implemented.  All information was protected through the academic center and data was not 
replicated for outside use.  The data collected was from documentation from the surgical list of 
the number of patients who received a kidney and liver transplantation.  Other data collected was 
derived from the charts of patients who received a kidney or liver transplantation and the number 
of patients meeting criteria for consultation (See Appendix L).  This data was utilized to 
determine the percent of appropriate consultations after pathway implementation.  
Steps for Implementation of Project, including Timeline 
     During the implementation of the project, the DNP student (See Appendix H): 
 Gathered data and best practices from the literature, collected data (risk factors for 
PTDM) from the organizational assessment which guided in developing the pathway. 
 Developed a nurse driven clinical pathway for endocrinology consultation utilizing the 
data from the organization and current literature (See Appendix I). 
 Presented pathway to the endocrinology team for review and recommendations. 
 Elicited recommendations from endocrinology team and made corrections. 
 Obtained approval of new clinical pathway from GMS service. 
 Obtained clinical pathway approval from Glycemic Control Committee (GCC). 
 Obtained approval from nurse managers and education coordinators on CTICU and the 
step down unit. 
 Presented clinical pathway for approval to Nursing Policy and Procedure Subcommittee 
and Nursing Professional Practice Committee. 
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 Educated all nursing staff on CTICU and the step down unit, through several sessions of 
in-service education (See Appendix I, J).  Staff understanding of new pathway was 
determined by a sign off sheet and post survey that stated staff understood new criteria 
and clinical pathway, when implementation would occur, and their responsibilities (See 
Appendix K).  
 Implemented clinical pathway on CTICU and the step down unit. 
 After one month of implementation, evaluated clinical pathway using an evaluation tool.  
This tool evaluated how many patients were transplanted, how many met the criteria, and 
how many were consulted appropriately (See Appendix L).  
 Compared before and after consultation rates by utilizing the evaluation tool (See 
Appendix L). 
 Discussed results with the endocrinology team at the Glycemic Control Committee 
(GCC) and quality meetings. 
 Evaluated current clinical pathway and made recommendations for further changes and 
possible implementation of expanding the pathway for outpatient setting in this transplant 
population. 
 Disseminated results of the final project at Grand Valley State University Kirkhof 
College of Nursing during the final defense of the project.  
Ethical and Human Subjects Protection 
     With the QI initiative, no contact of human subjects occurred during this project intervention.  
Data was collected but protected under the protocols regarding de-identification under the 
academic medical center.  An application was submitted and approved through Grand Valley 
State University (GVSU) Human Research Review Committee’s (HRRC) for Institutional 
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Review Board (IRB) determination.  The IRB found that the project was quality improvement 
and not research.  There was already an exempt status granted by the IRB at the academic 
medical center, for a larger project that the DNP student was working on with other members at 
the organization (See Appendix M). 
Budget 
     Cost considerations for this project required human resources and time of the endocrinology 
team working together to approve a clinical pathway for endocrinology consultation.  Additional 
resources involved the time necessary to train nursing staff on the pathway implementation as 
well as the financial cost of sustainability, cost of staff in service education, and the use of 
conference rooms for educational sessions.  Furthermore, the cost of time from stakeholders, 
managers, educators, endocrine service, transplant team, and the DNP student to review, 
approve, and implement the quality improvement project was taken into consideration.  
     Based on the average wages of an endocrinologist, a nurse practitioner, a nurse, and a project 
coordinator along with the time utilized to implement this project (in hours), a monetary value on 
the time spent implementing this project was calculated (Hospital in Midwest, 2016; 
Payscale.com, 2016; Salary.com, 2016).  Other expenses included the education materials and 
laminated documents that were placed in each patient room on CTICU and the step down unit for 
project implementation.  The total expenses were $3981.97 for this project implementation (See 
Appendix N).  
     Endocrinology consultations are a surrogate measure to potentially result in improved 
outcomes of glycemic control.  Appropriate consultations to address glycemic control have the 
potential to decrease readmissions driven by poor glycemic control which then leads to cost 
savings.  The readmission rates at this academic medical center within 30 days post-transplant 
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range from 16% for liver transplant patients to 31% for kidney transplant patients, averaging two 
patients readmitted per quarter (K. Thomas, personal communication, June 6, 2016).  The 
average length of stay (LOS) for these patients once they are readmitted range from 7.7 days for 
liver transplants to 9.9 days for kidney transplant patients.  The reasons for readmission are 
potentially driven by poor glycemic control: infection, acute rejection, or hyperglycemia (K. 
Thomas, personal communication, June 6, 2016).   
     The fixed cost for 24 hours for a patient in the CTICU is $4100.00 compared to $1889.00 on 
the step down unit (Hospital in Midwest, 2016).  Analyzing this data along with the LOS for 
readmissions for kidney and liver transplantations, the expense of one kidney transplant patient 
readmitted ranges from $18,701.00-$40,590.00.  Whereas, the expense of one liver transplant 
patient readmitted ranges from $14,545.30-$31,570.00 (See Appendix O).  Therefore evaluating 
the cost of the project implementation compared to the cost of one patient readmitted, there is a 
potential savings of $14,719.03-$36,608.03 for preventing readmission in the kidney transplant 
population.  Whereas the potential savings for liver transplantation is $10,563.33-27,588.03 (See 
Appendix P).  From this data, estimated quarterly savings can range from $29,438.06-$73,216.06 
for kidney transplant patients and $21,126.66-$55,176.06 for liver transplant patients.  Therefore, 
there is an estimated potential yearly cost savings as high as $292,864.24 for kidney transplant 
patients and as high as $220,704.24 for liver transplant patients if eight readmissions per year 
were prevented (See Appendix Q).  
Project Outcomes 
     One month after project implementation, the DNP student collaborated with the transplant 
quality leader and collected data on the number of kidney and liver transplantations that occurred 
from May 2-May 31, 2016.  Other data collected consisted of the number of patients meeting 
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criteria for consultation per the new pathway, and how many appropriate endocrinology 
consultations actually occurred.  This data will then be disseminated to the endocrinology and 
transplant team during the July quality meetings in the form of charts that list how many 
transplants occurred during this time, how many transplants met criteria (percentage), and how 
many patients meeting the criteria were actually consulted (percentage).  Another chart will show 
the comparison of appropriate consultations before and after pathway implementation.  As a 
result of this quality improvement project, the following outcomes were realized: 
 A nurse driven clinical pathway was created that established criteria for endocrinology 
consultation in kidney and liver transplantation on May 2, 2016. 
Outcome measure: Transplant nurse practitioners, surgical intensive care unit (SICU) 
physicians, endocrinology team, transplant pharmacists, nurse managers, education 
coordinators, quality teams on CTICU and the step down unit, and nursing committees 
approved criteria and the clinical pathway based on current literature and organizational 
needs (See Appendix I).  Approval was met prior to the May 2, 2016 project 
implementation.  
 Nursing staff knowledge was evaluated after in-service and implementation of nurse 
driven clinical pathway on May 2, 2016. 
Outcome measure: The majority of nursing staff (97% on CTICU and 85% on the step 
down unit) completed in-service education (Appendix J) and a post survey (Appendix K).  
The majority of nurses (92%) felt the clinical pathway pertained to their job, 90% stated 
that they understood the purpose and criteria needed to consult the endocrinology service, 
and 80% understood their responsibilities pertaining to the clinical pathway.  However 
only 60% of nurses felt the pathway would improve their work load, whereas, only 4% 
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felt the pathway would create more work for them.  Nurses felt the potential barriers that 
would prevent them from consulting endocrinology were remembering to page, 
weekend/night shift coverage would not be responsive, receptive, or kind; increased 
glucose checks obtained by nursing, and there was a concern of pushback from the 
transplant team for when nursing would place the order (See Appendix R). 
 Data was analyzed on the number of consultations that were obtained after pathway 
implementation on June 7, 2016. 
Outcome measure: Data was assessed and evaluated regarding a change in appropriate 
consultation rates with the new pathway.  Normally over 30 transplants occur per month.  
However, in the month of implementation, 21 transplantations occurred (16 kidney and 5 
liver).  Of the patients consulted to endocrinology, 100% of those consultations were 
appropriate.  However, 19% of patients were not consulted according to the criteria of the 
pathway (See Appendix S).  The barriers to consultation were:  
o Nurses on units failed to place order for consult (underlying reason unknown) 
o Transplant team failed to place order for consult when the patient was on an 
insulin drip in the operating room.  The team stated they felt the order/consult was 
unnecessary. 
o Nurses on step down unit failed to obtained glucose checks per the guidelines of 
the pathway.  Hyperglycemia was noted from the labs obtained daily. 
 The appropriate number of consultations to the endocrinology service were evaluated on 
June 7, 2016. 
Outcome measure: From the data collected after a month after project implementation, 
appropriate consultations occurred.  Comparing the data before the pathway 
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implementation to after implementation, there has been a 4% reduction in missed 
consultations in kidney transplantation and a 2% reduction in missed consultations with 
liver transplantations (See Appendix S).  When performing the Chi-square test, there was 
not statistically significant evidence (p = 0.948) to conclude that appropriate consultation 
to the endocrinology service and abnormal glucose in the post-transplant period were 
related (See Appendix S).  However, a larger sample could have affected statistical 
significance (N = 21).  Even though there was not a statistically significant change in 
number of consultations, there was a clinical meaningful difference because the patients 
who were consulted after pathway implementation received the benefit of management 
by endocrinology specialists to improve glycemic control post transplantation.  Therefore 
the recommendation for future study would be a longer evaluation period to determine 
true significance level.  Project results will be disseminated during the July quality 
meetings to the  transplant and endocrinology teams regarding the number of appropriate 
consultations with new clinical pathway implementation to serve as a guide for a longer 
implementation period of current pathway as well as possible expanded pathways to 
include the outpatient setting in this transplant population. 
Implications for Practice 
     Up to 30% of all patients with solid organ transplantation will develop PTDM (United 
Networking for Organ Sharing, 2015).  Since there is an inconsistent definition of PTDM, proper 
identification of patients at risk of PTDM, and with utilization of the evidence from the current 
literature, interventions can be implemented to improve glycemic control in a transplant center.  
Utilizing the Donabedian model that guides quality improvement efforts to improve outcomes, 
evidence suggests that with pathways in place to guide appropriate consultation with 
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endocrinology teams, treatment to control blood sugar is initiated.  The process of improved 
glycemic control along with proper education and resources on the nursing units, patient 
outcomes could potentially lead to improved control that results in a decreased risk of 
cardiovascular morbidity, reduced graft function, and mortality (Midtvedt et al., 2011).  The 
recommendation is for transplant and endocrinology teams to continue to work together to 
develop clinical pathways to appropriately consult endocrinology teams that is consistent with 
the standardized care of other organ transplants.  Though this is a small piece to a larger 
problem, the use of standardized pathways will potentially improve care leading to improved 
glycemic control in the kidney and liver transplant population.  Early consultation immediately 
after surgery will potentially improve the transitions of care from inpatient to outpatient setting 
for this patient population.  Further implications for determining the effects of appropriate 
consultation beyond this study should be formally determined as a recommendation following 
this QI intervention.  Based on this project implementation, there were important 
successes/difficulties encountered, project strengths, opportunities for improvement, and 
sustainability factors addressed, limitations to the quality improvement project, and the period 
after the project.  Also a reflection of the Essentials of DNP education were utilized during this 
QI intervention (American Association of Colleges of Nursing, 2006). 
Successes of Project  
     Throughout the development and implementation of this project, several members of the 
transplant team, surgical intensive care unit (SICU) team, endocrinology team, pharmacy team, 
nursing, and quality team stated that there was a better working relationship and communication 
among the disciplines.  These disciplines worked together on a project and collaborated on 
establishing a pathway for an issue that has been a topic of discussion for years with no 
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resolution.  A theme of empowerment emerged during the in service educational sessions where 
the nurses stated they “felt they had direction on an issue and felt they could do something to 
improve patient outcomes.”  Nurses also felt empowered after the DNP student presented at 
nursing committees and the nurses stated this project could be implemented in other departments 
to improve patient outcomes.  This project ultimately empowered disciplines, especially nursing, 
about the importance of glycemic control in transplantation which can then be utilized in other 
departments in the hospital. 
Difficulties of Project 
     There were many difficulties to overcome with this project implementation.  Many of these 
difficulties were associated with the structure and processes within the organization.  First of all 
empowering multiple disciplines with the concept of change and the positive outcomes that can 
occur when change is present was more difficult to overcome because of the organizational 
barriers that occurred in this large medical center.  One organizational barrier was managing 
differences in opinions among transplant and endocrinology providers.  Another example of an 
organizational barrier was understanding the stakeholders’ level of support for quality 
improvement.  These stakeholders (i.e. members of the transplant team) would collaborate on the 
project but then they would refuse to place orders for nurses to obtain glucose monitoring on 
their patients.  These same stakeholders stated they supported the pathway but would not take 
responsibility for the process changes that occurred in the transplant patient population.  Another 
difficulty was understanding the staffing barriers and processes on the nursing units and how the 
level of autonomy was different among team members on the various units.  Staff on the step 
down unit had a culture where the nurses are driven by tasks and they would not monitor a 
glucose level despite the pathway guidelines unless an order was placed.  In contrast, the CTICU 
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nurses would monitor glucose levels regardless of the order status.  This difference was 
significant and was illustrated during the evaluation process of the project when reasons for not 
monitoring glucose levels was determined by provider order status.  
Strengths of Project 
     The strengths of the project were the collaboration of leaders and clinicians in the field of 
endocrinology and transplant teams working together to improve the quality measures of 
glycemic control in the transplant population.  Also there was support for the clinical pathway 
and project implementation from multiple disciplines including nursing committees as illustrated 
by their approval at several presentations and meetings.  Another strength to the project was the 
DNP student has worked at the large academic center for nearly eight years and has developed 
positive working relationships with multiple disciplines.  These supportive relationships allowed 
meetings with stakeholders to occur in a timely fashion since the meetings may not have 
occurred if the DNP had not already established these professional connections.  From this 
networking, there was support for this project which allowed implementation of pathway that 
standardized the care among all transplant patients.  
Weaknesses of Project 
     Weaknesses in the project was lack of collaboration with all of the endocrinology team (i.e. 
fellows) when creating the guidelines for the clinical pathway.  This was a strategic move to 
avoid potential opposition from these members.  However, these same members were the 
physicians taking call on nights and weekends where the nurses already felt these people would 
be a barrier to endocrinology consultation.  Preventing these key stakeholders from collaborating 
in the development of the pathway still caused confusion and opposition once the pathway was 
implemented.  This avoidance could have potentially affected the sustainability of the pathway.  
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Another weakness to the project was lack of consideration of the culture of nursing regarding 
clinical decision making.  Nurses on the step down unit stated they did not feel comfortable 
monitoring glucose levels without an order despite the guidelines of the pathway.  The status of 
the transplant order sets and the lack of an order to monitor glucose levels was not discussed as a 
potential concern of project implementation.     
     Another weakness of this project was lack of consideration that the pathway may not be 
appropriate for all transplant patients (i.e. readmissions).  This pathway purposely had a low 
threshold of criteria for endocrinology consultation.  Whereas transplant patients who are 
readmitted may or may not fit the same criteria as immediate post-transplant patients, causing 
inappropriate consultations.  Even though this project did not evaluate transplants patient who 
were readmitted, this weakness could cause opposition for further pathway implementation.  
     As much as this was a strength, the DNP student working at the organization of 
implementation also served as a weakness.  There were boundaries crossed when the student was 
in her working role compared to when she was in her student role.  Many disciplines often 
referred to this pathway as the “DNP student’s pathway” even though the pathway was approved 
by nursing committees and other interdisciplinary committees.  This weakness was also 
compounded with the kidney and liver transplant team having opposing views of glycemic 
control which often was discussed with the DNP student even during her working hours.  Finally 
a weakness of this project was not having the appropriate staff to manage the influx of patients 
who were consulted to the endocrinology service.  The management of these additional patients 
were discussed but no solid plan was developed to fully handle the patient load caused from the 
project. 
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Limitations of Project 
     Limitations to this study included lack of a pre and posttest for the nursing staff as well as 
limited content questions on the survey during the in-service.  This occurred because there was a 
lack of time for the in-service and the pretest was in a form of open discussion with the nursing 
staff regarding their current knowledge of glycemic control.  However for future project 
implementations, a pre and posttest along with more content questions on the survey would be 
encouraged.  There was also a short evaluation period after implementation.  The data collected 
prior to implementation occurred over three months.  Whereas, the evaluation period was only 
one month.  Additionally, the project implementation occurred during a time of low volume of 
transplantations (n=21).  Normally, over 30 transplantations occur each month.   Therefore the 
true significance of this project was not completely accurate to determine the full implications of 
practice moving forward.  Finally, the project only evaluated patients who were immediately 
post-transplant.  The implications of practice for all transplant patients on these nursing units was 
not addressed in the evaluation of the pathway.  
Sustainability 
     Prior to the project implementation, no interventions to address glycemic control post-
transplant for kidney and liver patients had been trialed before at this organization.  For years, 
glycemic control improvement among transplant patients has been a topic of discussion with no 
resolution.  In the past, members of both endocrinology and transplant teams had opposing views 
of glycemic control, resulting in no previous pathway implementation.  Therefore, strategic 
pathway revisions are key to stakeholder support and sustainability.  With transplantation highly 
regulated, these interventions will not only affect patient outcomes and improve patient safety; 
but could improve the centers approval status with Centers for Medicare and Medicaid Services 
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(CMS) by improving transplantation outcomes (Centers for Medicare & Medicaid Services, 
2015).  Moving forward, recommendations for clinical pathway sustainability consist of: 
 Evaluating the pathway after three months or until there is a sample size greater than 30.  
The current evaluation period was too short with a small sample size (n=21) to provide 
data to show statistical significance for or against the pathway.  
 Re-evaluating the pathway criteria that would initiate consultation.  This evaluation 
would determine if the criteria encompasses all of the transplant population, not just 
immediate post-transplant patients as well as determine if the pathway’s criteria threshold 
is too low for all of the transplant patients.  
 Designating a member from the GCC team to take over the pathway implementation after 
the DNP student has completed the project to continue the quality process improvement 
measures that the revisions of the pathway would allow.  
 Working with quality leaders to have glucose monitoring part of the transplant order sets.  
A weakness in this study was determining that nurses were not monitoring glucose levels 
because there was not an order placed.  For project sustainability, establishing glucose 
monitoring in the order sets may encourage nurses to be compliant with the pathway 
guidelines.  
 Empowering the transplant team to have accountability for the glycemic control of their 
patient population.  The current culture at this center focuses more on immediate 
transplantation outcomes instead of long term glycemic control in this patient population.   
 Establishing a business plan to monitor and evaluate the current staff who would manage 
the influx of patients who are consulted to endocrinology.  This project study illustrated 
an influx of patients for the endocrinology service that over time could be difficult to 
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manage with their current staff.  This business plan would include the use of full time 
employees to manage the pathway, triage acute needs for this patient population, allocate 
resources, and provide clinical decision support.  
 Considering the cost of a future project implementation and potential cost savings of the 
QI improvement project.  Including the cost considerations, there is an estimated 
potential yearly cost savings as high as $292,864.24 for kidney transplant patients and as 
high as $220,704.24 for liver transplant patients if glycemic control could be improved. 
Essentials of DNP Education  
     The DNP prepared nurse strived to delineate the doctor of nursing practice (DNP) Essential 
competencies along with theory to guide practice during this project implementation (American 
Association of Colleges of Nursing, 2006).  These competencies, served as a foundation, 
provided the leadership principles that ensured quality improvement in the organization, and 
analyzed clinical scholarship to implement evidence based practice.  Several of the DNP 
essentials were utilized during this project.    
     Essential I: Scientific Underpinning for Practice.  This Essential provides the scientific 
basis necessary for advanced nursing practice (AACN, 2006).  This Essential was enacted by the 
DNP student obtaining an extensive organizational assessment and literature review for this 
quality improvement project.  This Essential was delineated in the frequent meetings with the 
mentor and members of endocrinology at the organization, in the evaluation of the pathway and 
in making changes based on knowledge from other disciplines before project implementation. 
     Essential II: Organizational and Systems Leadership for Quality Improvement and  
     Systems Thinking.  This Essential describes the preparation needed in the organizational and 
systems leadership that affects the delivery in health care and patient outcomes (AACN, 2006).  
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This Essential was delineated in this project by the DNP student working and collaborating with 
the transplant quality leader on the process improvement measures, dashboards, and metrics used 
at the transplant center.  The DNP student also attended several kidney and liver quality 
meetings, shadowed the medical quality leader, and incorporated the existing DMAIC QI 
framework of the organization to improve successful implementation. 
     Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice.  
Essential III describes the evaluation, integration, translation, and application of evidence-based 
practices (AACN, 2006).  The competency for this Essential was met with the implementation 
and evaluation of the QI project.  The utilization of evidence based practices guided the 
implementation to analyze, predict, and disseminate findings to improve healthcare outcomes.  
The DNP student also collaborated with quality leaders, project coordinators, and multiple 
disciplines in identifying the gaps in evidence based practice at this organization.  
     Essential VI: Interprofessional Collaboration for Improving Patient and Population  
     Health Outcomes.  This Essential concentrates on the importance of expanding 
interprofessional collaboration, ensuring that the DNP student will develop the expertise needed 
to assume leadership roles as well as participate in the work environment alongside collaborating 
teams (AACN, 2006).  This Essential was met by the DNP student providing effective 
communication and collaboration developing the pathway with the mentor and members of the 
endocrinology team.  The Essential was also delineated with one on one meetings with key 
stakeholders (i.e. SICU team, members of transplant team), the DNP student’s presentation of 
pathway to the step down unit’s quality meetings, nursing committees, and transplant pharmacy 
staff meetings.  The DNP student also performed educational in-services to over a 100 nurses, as 
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well as, collaborated with nurses, pharmacy, transplant, and endocrinology teams to discuss 
solutions to potential barriers of project implementation. 
     Essential VIII: Advanced Nursing Practice.  This Essential describes the clinical 
specialization content of the advanced nursing practice through the development of therapeutic 
relationships with patients and providers, utilization of advanced clinical decision making, and 
mentoring others in the nursing profession (AACN, 2006).  This Essential was delineated in this 
project by the DNP student presenting at the organization’s outcomes research collaborative 
meeting with the discussion consisting of the enactment of the DNP as well as the clinical 
pathway implementation.  The DNP student also guided and mentored nurses on the project 
implementation as well as developed and sustained therapeutic relationships with multiple 
disciplinary teams for optimal patient outcomes. 
Dissemination of Outcomes 
     Dissemination of results will first occur with the stakeholders at the organization where 
project implementation occurred.  The DNP student will present at the July, 2016 quality 
meetings.  The final presentation will be to the DNP student’s committee at the scholarly project 
defense.  Final project results will be disseminated in the future at the organization’s research 
committees, in future poster presentations at conferences, and possible journal publications.   
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Appendices 
Appendix A: The Donabedian Model 
 
Figure A. The Donabedian Model. Reprinted from “Evaluating the quality of medical care,” by A. Donabedian, 
1966, Milbank Memorial Fund Quarterly, 44, p. 166-206. Copyright 2004 by jasn.asnjournals.org. Reprinted with 
permission.  
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Appendix B: The Define Measure Analyze Improve Control (DMAIC) Process 
 
 
 
 
 
 
 
 
 
 
Figure B. DMAIC Model. Reprinted from Villanova University by University Alliance, 2016, Retrieved from 
http://www.villanovau.com/resources/six-sigma/six-sigma-methodology-dmaic/#. VxL7XvkrLX4. Copyright 2016 
by University Alliance. Reprinted with permission.  
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Appendix C: SWOT Analysis for Academic Medical Center 
Strengths Opportunities 
 Leading hospital in Midwest for education, 
research, and patient care 
 Magnet certified 
 Transplant center serves as the largest and 
most successful transplantation program in 
Illinois 
 Transplant center ranked top nationally in 
patient outcomes and transplant performed 
 Over 200 kidney transplants yearly 
 Over 100 liver transplants yearly 
 Several satellite clinics 
 Developed Real-time Analysis and 
Performance Improvement Dashboard 
(RAPID) for quality improvement 
 Committed to our patients 
 Strong leadership 
 Improve wait times for organ transplantation 
 Change in allocation system for organ 
transplantation 
 Heavy regulation to ensure safe and effect 
transplant system 
 No change in reimbursement with Affordable 
Care Act 
 United Network for Organ Sharing (UNOS) 
has changed criteria for who is listed 
 RAPID software to improve quality assurance 
 Improve patient satisfaction with improved 
discharge planning 
 Improve patient follow up with appropriate 
consultations 
Weaknesses Threats 
 Lack of communication among staff members 
 High turnover rates among staff 
 Divided health care culture 
 Divided viewpoints among surgeons 
 Poor follow up with patients 
 Overbooked clinic days 
 Poor patient satisfaction  
 Poor discharge teaching  
 Changing electronic health record systems 
 Possible probationary period from regulating 
bodies from poor patient outcomes from 
Scientific Registry of Transplant Recipients 
(SRTR) reports 
 Complete closure of transplant program 
 Government regulations 
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Appendix D: Fishbone diagram of Poor Glycemic Control 
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Appendix E: Non-Glucose Management Service Consults and Status 
11/1/2014-2/28/2015 
 
 Patients Patients with History of 
DM (%) 
Kidney 43 10 (23%)  
Liver 18 4 (22%) 
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Appendix F: Non-Glucose Management Service Consults and Glucose Outcomes 
11/1/2014-2/28/2015 
 
 Patients ≥2 BG values    
<60 mgdl 
≥2 BG values    
BG>200mgdl 
Both Hypo 
and Hyper 
Kidney 43 22 (51%) 5 (11%) 7 
Liver 18 0 12 (67%) 3 
Total  61 22  17  10  
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Appendix G: Kidney Transplantations with Risk Factors 
11/1/2014-2/28/2015 
 
 Total 
Transplants 
Age>45 BMI>25 
kg/m² 
History 
of DM 
African 
American/Hispanic 
Hyperglycemia 
BG>140 
Kidney 61 36 (60%) 30 (49%) 27 (44%) 23 (38%) 20 (33%) 
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Appendix H: Implementation of Project Timeline 
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Appendix I: Criteria for Nurse Driven Diabetes Clinical Pathway in Kidney/ Liver 
Transplantation 
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Appendix I: Abbreviations Key for Clinical Pathway 
 
GMS = Glucose Management Service 
gtt = drip 
Q = every 
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Appendix J: Education Materials 
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Appendix K: Nurse Driven Clinical Pathway Survey 
 
Nurse Driven Clinical Pathway Survey 
For each of the statements below, circle the response that best characterizes how you feel about 
the statement, where 1= Strongly Disagree, 2=Disagree, 3=Neutral, 4=Agree, and 5=Strongly 
Agree 
 
 Strongly 
Disagree 
Disagree Neutral Agree 
Strongly 
Agree 
 
The in-service pertains to my job 1 2 3 4 5 
I understand the purpose and criteria 
needed to consult endocrinology 
1 2 3 4 5 
I understand my responsibilities 
pertaining to the clinical pathway 
1 2 3 4 5 
I feel the clinical pathway will 
improve my work load 
1 2 3 4 5 
I feel the clinical pathway will cause 
more work for me 
1 2 3 4 5 
 
 
Please list potential barriers that would prevent you from consulting endocrinology? 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
_____________________________________________________________________________ 
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Appendix L: Evaluation Tools 
 
 
TX  
# 
Hx 
of 
DM 
 
Hyperglycemia 
2X>140 or 
1X >250 
Hypoglycemia 
1X<60 or 
2X<70 
Insulin 
gtt 
Y or N 
Supplemental 
Insulin 
Y or N 
Was Pt 
consulted 
Y or N 
Did pt 
meet 
criteria 
Barriers to 
consultation 
1         
2         
3         
4         
5         
6         
7         
8         
9         
10         
 
 
Total Transplants 
Total Consulted 
Appropriately (%) 
Should have been Consulted 
(%) 
   
 
 
Type of Transplant 
Consults Missed before 
Pathway Implementation 
(%) 
Consults Missed after 
Pathway Implementation 
(%) 
Kidney   
Liver   
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Appendix M: IRB Letters 
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Appendix N: Expense Report for Project Implementation  
 
Expenses Average Salary/Wage 
Hours (Time in 
meetings/education) 
Total 
Cost 
2 Endocrinologists 
$101.00 per hour 
($211,000 per year based 
on 40 hour work week) 
5 $1,010.00 
1 Project Coordinator 
$21.90 per hour 
($45,560 per year based 
on 40 hour work week) 
5 $109.50 
1 Nurse Practitioner 
$50.20 per hour 
($104,379 per year based 
on 40 hour work week) 
5 $250.00 
DNP Student $40.00 per hour 30 $1200.00 
106 Nurses $40.00 per hour 26.5 $1,060.00 
Education Materials/ 
Laminated Documents 
  $352.47 
Total   $3,981.97 
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Appendix O: Readmission Expenses for one Kidney and Liver Transplant Patient  
 
Readmission Expenses for a Kidney Transplant Patient  
 
Readmission Expenses for a Liver Transplant Patient  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unit 
Fixed Room Rate 
for 24 hours ($) 
Average Length of 
Stay (LOS) 
Total 
CTICU $4100.00 9.9 $40,590.00 
Step Down Unit $1889.00 9.9 $18,701.10 
Unit 
Fixed Room Rate 
for 24 hours ($) 
Average Length of 
Stay (LOS) 
Total 
CTICU $4100.00 7.7 $31,570.00 
Step Down Unit $1889.00 7.7 $14,545.30 
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Appendix P: Cost Savings for Kidney and Liver Transplantation 
Cost Savings for Kidney Transplantation  
 
 
 
 
 
 
 
 
 
 
Cost Savings for Liver Transplantation  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CTICU Step Down Unit 
Readmission 
Expenses 
(one Patient) 
$40,590.00 $18,701.00 
Project 
Implementation 
Expenses 
$3,981.97 $3,981.97 
Total Cost Savings $36,608.03 $14,719.03 
 CTICU Step Down Unit 
Readmission 
Expenses  
(one Patient) 
$31,570.00 $14,545.30 
Project 
Implementation 
Expenses 
$3,981.97 $3,981.97 
Total Cost Savings $27,588.03 $10,563.33 
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Appendix Q: Estimated Quarterly and Yearly Cost Savings for Kidney and Liver 
Transplantation 
 
Estimated Cost Savings for Kidney Transplantation 
 
 
 
 
 
 
 
 
 
Estimated Cost Savings for Liver Transplantation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quarterly  
(based on 2 
readmissions per 
quarter) 
Yearly 
CTICU $73,216.06 $292,864.24 
Step Down Unit $29,438.06 $117,752.24 
 
Quarterly  
(based on 2 
readmissions per 
quarter) 
Yearly 
CTICU $55,176.06 $220,704.24 
Step Down Unit $21,126.66 $84,506.64 
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Appendix R: Nurse Driven Clinical Pathway Survey Results 
 
Please list potential barriers that would prevent you from consulting endocrinology? 
 Remembering to page Endocrinology 
 Weekend/night shift coverage not responsive, receptive, or kind 
 More frequent glucose checks obtained by nursing 
 Concern of pushback from transplant team for placing order 
 
 
 
 
 
53%
4%
11%
14%
29%
8%
10%
20%
22%
3%
92%
90%
80%
60%
4%
The in-service pertains
 to my job
I understand the purpose
 and criteria needed to
 consult endocrinology
I understand my
 responsibilities pertaining
to the clinical pathway
I feel the clinical pathway
 will improve my work load
I feel the clinical pathway
 will cause more work for me
Nurse Driven Clinical Pathway Survey
Strongly Disagree Disagree Neutral Agree Strongly Agree
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Appendix S: Evaluation of Project 
 
TX  # 
Hx 
of 
DM 
 
Hyperglycemia 
2X>140 or 
1X >250 
Hypoglycemia 
1X<60 or 
2X<70 
Insulin 
gtt 
Y or N 
Supplemental 
Insulin 
Y or N 
Was Pt 
consulted 
Y or N 
Did pt 
meet 
criteria 
Barriers to 
consultation 
1 
DD 
Kidney 
No Yes No No No Yes Yes 
 
2 
DD 
Kidney 
No Yes No Yes No No Yes 
Tx team failed 
to place order 
for consult. 
Patient was on 
Insulin gtt in 
the OR.  
3 
DD 
Kidney 
No Yes No No No Yes Yes 
 
4 
LD 
Kidney 
Yes Yes Yes No Yes Yes Yes 
 
5 
DD 
Kidney 
No Yes No No Yes Yes Yes 
 
6 
DD 
Kidney 
No Yes No No No Yes Yes 
 
7 
LD 
Kidney 
No Yes No Yes Yes Yes Yes 
 
8 
LD 
Kidney 
No Yes No No Yes Yes Yes 
 
9 
DD 
Kidney 
No Yes No Yes No Yes Yes 
 
10 
LD 
Kidney 
No Yes No No No Yes Yes 
 
11 
DD 
Kidney 
Yes Yes No No Yes Yes Yes 
 
12 
LD 
Kidney 
No Yes No No No No Yes 
Nurses on step 
down unit failed 
to check 
glucose levels 
per guidelines 
of pathway 
13 
LD 
Kidney 
No Yes No No Yes Yes Yes 
 
14 
DD 
Kidney 
Yes Yes No Yes No Yes Yes 
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15 
DD 
Kidney 
 
No Yes No Yes No Yes Yes 
 
16 
LD 
Kidney 
No Yes No No Yes No Yes 
Nurses failed to  
place order for 
consult 
17 
LD 
Liver 
No Yes No Yes Yes Yes Yes  
18 
DD 
Liver 
No Yes Yes Yes No Yes Yes  
19 
DD 
Liver 
No Yes No Yes Yes Yes Yes  
20 
DD 
Liver 
No Yes No Yes No No Yes 
Nurses failed to  
place order for 
consult 
21 
DD 
Liver 
Yes Yes No Yes Yes Yes Yes  
 
Total Transplants 
Total Consulted 
Appropriately (%) 
Should have been Consulted 
(%) 
21 transplants 
(16 Kidney, 5 Liver) 
100% 
19% (N= 3) 
 (19% Kidney, 20% Liver) 
 
Type of Transplant 
Consults Missed before 
Pathway Implementation 
(%) 
Consults Missed after 
Pathway Implementation 
(%) 
Kidney 23% (N=10) 19% (N=3) 
Liver 22%  (N=4) 20% (N=1) 
 
Chi-Square Test for Significance of Appropriate Consultation to Endocrinology and 
Abnormal Glucose for Post-Transplantation 
Observed Values     Expected Values 
 
p- value = 0.948 (p<0.05 shows significance) 
 
 
 
 Yes No Total 
Kidney Transplants 13 3 16 
Liver Transplants 4 1 5 
Total 17 4 21 
 Yes No Total 
Kidney Transplants 12.95 3.05 16 
Liver Transplants 4.05 0.95 5 
Total 17 4 21 
